Introduction
Natural, synthetic, semisynthetic, or natural product-derived alkaloid compounds are important sources of new drugs and have a variety of biological activities in clinical trials. Naturally occurring quinolines have been identified and reported to possess a high degree of various biological activities.
1,2 Graveoline 3 and chimanine 4,5 are alkaloids isolated from Ruta graveolens L. and Galipea longiflora, respectively, and showed comprehensive pharmacological activities such as antibacterial and antitumor activities. 6−11 Tumor angiogenesis is a promising target of cancer therapy. A series of graveoline derivatives has been synthesized and tested for their antiangiogenesis activities.
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The quinoline core has been synthesized previously by various conventional strategies such as Skraup, 12 * Correspondence: yayli@ktu.edu.tr
Friedlander, 13, 14 Pfitzinger, 15 and Pavarov. 16 These classical synthetic methods are still frequently used for the preparation of quinolines. However, in this work, a new and practical method was used for the synthesis of substituted quinoline derivatives. The reaction sequence consists of an initial Aldol condensation (1-3) and then intramolecular Michael addition of amines to an α ,β -unsaturated carbonyl group using K-10 clay under solvent-free conditions using a microwave to give compounds 4-6, and finally air oxidation of compounds 4-6 with alkyl halide under basic conditions afforded the target compounds 7a-k, 8a-k, and 9a-k.
Heterocyclic systems with a quinoline are widely used in medicinal chemistry 17 and display many different biological activities such as antiparasitic, 18 antibacterial, 2 cytotoxic and antineoplastic, 19 antimycobacterial, 20 and antiinflammatory activities. 21 The biological activities of quinolin-4(1H)-one moiety depend on the bicyclic heteroaromatic pharmacophore as well as on the peripheral substituents and their spatial relationship. A number of 2-phenylquinolone derivatives with a phenyl group attached to the C-2 position of quinolin-4(1H)-one have expressed antimitotic activity. 22 In spite of their wide range of pharmacological activities, very few activity studies have been reported against tuberculosis for these group of compounds in comparison with other classes. 23 Tuberculosis is one of the most important diseases worldwide, with approximately three million deaths per year. 24 Tuberculosis is a problematic disease especially with respect to the ease of the spread of HIV infection and the increases in the prevalence of drug resistance as well as multidrug-resistant strains. 25 New synthetic compounds are certainly required for the long-term control of tuberculosis.
On the basis of these observations and as a part of our continued research for new antimicrobial and antioxidant agents, we report an efficient and simple method for the synthesis of 33 new series of quinolines derivatives 2-(2-, 3-, 4-fluorophenyl)-4-O-alkyl quinolines with an increasing number of carbons (C 5 -C 15 ) in the side chain. Thus, we wanted to determine the influence of the length of the carbon chain in the O-alkyl substituent of the synthetic compounds 7a-k, 8a-k, and 9a-k. The antimicrobial (antibacterial, antifungal, and antituberculosis) and antioxidant activities were also evaluated for the synthetic compounds 4-9.
Results and discussion

Chemistry
Many synthetic methods for quinoline synthesis have been used in the literature. [12] [13] [14] [15] [16] 26, 27 However, many of these classical synthetic approaches suffer from a limited source of precursors, harsh reaction conditions, and low yields and selectivity. We first synthesized substituted quinoline starting from flavonone and alkyl halide at room temperature, which was a single step process and which was a practical method for the synthesis of substituted quinoline derivatives. This method can be used for naturally occurring or synthetically prepared substituted quinolines starting from flavonones. The reaction sequences used for the synthesis of the target compounds (7a-k, 8a-k, 9a-k) are outlined in the Scheme. Flavonones of 2-(2-fluorophenyl),2,3-dihydroquinolin-4(1H )-one (4), 2-(3-fluorophenyl),2,3-dihydroquinolin-4(1H )-one (5), and 2-(4-fluorophenyl),2,3-dihydroquinolin-4(1H )-one (6) were synthesized through the cyclization of the correspond-
, and (2E )-1-(2-aminophenyl)-3-(4-fluorophenyl)prop-2-en-1-one (3), respectively, using K-10 clay under solvent-free conditions using a microwave at 85
• C (Scheme). Then compounds 4, 5, and 6 were dissolved in DMF and treated with KOH and alkyl halides (C 5 -C 15 -Br). The reaction mixture was stirred at room temperature overnight and then was treated with 20 mL of distilled water and extracted with CH 2 Cl 2 . The crude residue was purified by silica gel column chromatography to afford compounds 7a-k, 8a-k, and 9a-k in moderate yields (27%-51%). The reaction progress was monitored using thin layer chromatography. In order to improve the yield, the reactions were carried out at higher temperatures, but the flavonone ring was opened and N-alkyl derivatives of compounds 1, 2, and 3 occurred.
Scheme. Synthesis of the 4-alkoxy-2-arylquinoline derivatives (7a-k, 8a-k, and 9a-k).
The structures of the newly synthesized compounds 7a-k, 8a-k, and 9a-k were identified by spectroscopic data such as 1 H NMR, 13 C/APT NMR, 1 H-1 H COSY, UV-Vis, FT-IR, LC-MS/MS, and elemental analyses (Tables 1-9 ). The mass spectra of these compounds (7a-k, 8a-k, and 9a-k) showed molecular ion peaks at the appropriate m/ z values and the results are listed in Tables 1, 4 , and 7, respectively. In the 1 H and 13 C NMR spectra of compounds 7a-k, 8a-k, and 9a-k, in particular, H 3 showed peaks at δ H 7.2 (1H, s) and C 3 at δ C 98.2-102.1 ppm, which are an indication of quinoline ring systems. Moreover, the alkoxy moiety of products 7a-k, 8a-k, and 9a-k exhibited characteristic signals at δ H 4.2 (2H, t, J = 6.6) and δ C 68.4 ppm for -OCH 2 -in the 1 H (Tables 2, 5 , and 8) and 13 C NMR (Tables 3, 6 , and 9) data, 28,29 respectively.
Biological activities
Quinolines, 4(1H)-quinolines, and their hydroderivatives are the most biologically active natural and synthetic compounds. Quinine, cinchonine, graveoline, and chimanine alkaloid derivatives are well known bioac- Comp.
IR Formula
LC-MS/MS Yield mp UV-vis λ nm(log ε)
Elemental analyses data (%) 
First number is calculated value and second number is found value for C, H, and N. Table 5 .
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H NMR data of compounds 8a-k. a First number is calculated value and second number is found value for C, H, and N. 
In vitro antibacterial screening
The antimicrobial activities of three new series of 33 quinolone compounds 2-(2-, 3-, and 4-fluorophenyl)-4-O-alkyl(C 5−15 )quinolines (7a-k, 8a-k, and 9a-k) were tested against gram-negative, gram-positive, and antifungal bacteria. The experimental results showed that antimicrobial activity was more effective on the gram-positive bacteria than the others that were used. Additionally, the length of the alkyl chain on the quinolone ring increases and the antimicrobial activity decreases as its interaction with the membrane lowers. In the literature, quinolines including fluorine substitution showed antituberculosis activity against Myosotis tuberculosis bacteria type. 30 The compounds 4-6, 7a-k, 8a-k, and 9a-k were prescreened with an agar well diffusion assay at 500 µ g/mL concentration, and those that showed activity were further tested to determine their minimal inhibition concentration (MIC) values (Table 10) . The MIC values of tested compounds 7a-k, 8a-k, and 9a-k decreased slightly with the number of carbon atoms in the alkyl chain as shown in Figure 1 . It was difficult to attribute decreasing MIC values with the length of the carbon chain in the O-alkyl substituents. The antimicrobial activity of compounds 4, 5, and 6 showed that there was no adverse activity against grampositive and antifungal bacteria apart from compound 6 out of nine different bacteria types in total examined as gram-positive, acido-resistant, and antifungal bacteria. The antimicrobial results revealed that compounds 9d, 9e, and 9f only have higher activities against the gram-positive bacterium Enterococcus faecalis at a high concentration (500 µ g/mL) among other bacteria used in this work.
Furthermore, it was observed that initial compounds 4, 5, and 6 and apart from 7b and 7c out of synthesized compounds and all other compounds have activities against tuberculosis bacteria type Mycobacterium smegmatis. The experimental results showed that the longer the alkyl chain gets, the lower activity is for the tested compounds 7a-k, 8a-k, and 9a-k. 31 Antimicrobial activities of these three series of title compounds showed that 8a-k is the most active (MIC, 62.5-125 µ g/mL), 9a-k is the second (MIC, 125-250 µ g/mL, except 9h), and 7a-k is the least active (MIC, 125-500 µ g/mL) against tuberculosis bacteria (M. smegmatis). When the fluoride was substituted at the m-position of the target compounds 8a-k showed higher antituberculosis activity (MIC, 62.5-125 µ g/mL) than the other o-, and p-fluoride substituted compounds 7a-k (MIC, 250-500 µ g/mL, except compound 7a) and 9a-k (MIC, 125-250 µ g/mL, except compound 9h) (Table 10) , respectively.
In vitro antioxidant activity
Two or more antioxidant test methods with different strategies were generally utilized in antioxidant activity determinations. Antioxidant activity differences appear in many cases between the results of different assays due to different reaction mechanisms with varying effects of solvents and temperature, existence of sterical issues, pH, and the matrix components. In the current study, two widely used antioxidant test methods were used for the determination of antioxidant capacities of the synthesized compounds 7a-k, 8a-k, and 9a-k. The DPPH• radical scavenging test has been used extensively for various types of samples including synthetic compounds (Figure 2 ). 32 The ferric reducing/antioxidant power (FRAP) method has also been utilized in many investigations with synthetic organics (Figure 3 ). To overcome solubility issues of the compounds when the solutions are mixed with FRAP reagent, the original method 33, 34 has been modified to contain methanol in 3:2 ratio in water instead of using water as solvent in the preparation of FRAP reagent. In quinolines, antioxidant activity changes in accordance with the functional groups related to the quinoline core. For example, when phenolic hydroxyl groups or imine groups are connected to the quinoline ring, antioxidant activity increases. 35 When activities of DPPH, ABTS with 2-oxoquinoline, and of superoxide anion and hydroxyl radical are examined, it can be seen that they show a better performance than the commercial antioxidant butylated hydroxytoluene (BHT). 36 Moreover, when hydrogen sending groups are connected to elements with a 2-phenylquinoline-4(1H)-one core, antioxidant activities of FRAP and TBARS increase.
37−39
However, it is seen that the activity decreases when the length of the alkyl chain tied to the quinoline ring increases. 
DPPH• scavenging tests
Radical scavenging activity against DPPH• was determined by UV at 517 nm by using vitamin C as antioxidant standard. The values are expressed as SC 50 (mg/mL), the concentration of the samples resulting in 50%
scavenging of DPPH• radical. The SC 50 value of vitamin C (0.005 mg/mL) was determined to compare with synthesized compounds in the range of 0.032-12.482 mg/mL. The highest and lowest activities were observed from compounds 9b and 7j, respectively, as seen in Figure 2 . In this serial synthesis of alkylated derivatives of quinolone, DPPH• radical scavenging activity decreased with increasing number of alkyl carbons, evident from the increasing trend of SC 50 values from compounds 7a, 8a, and 9a to 7k, 8k, and 9k. An obvious irregularity was observed with some of the compounds in this sense, as for 9b, 9i, and 9j; the reason behind this could not be explained with the current data. Similar results were also observed with some other types of natural product analogues with alkyl substitutions. (%Scavenging values at 0.5 mg/mL compound concentration) assay results; R 2 value is 0.85.
Ferric reducing/antioxidant power (FRAP) test
The antioxidant activities of the synthesized samples were also determined by FRAP assay (Figure 3 ).
33,34
The method is based on measurement of the iron reducing capacities of the compounds. FRAP values were expressed as µ M obtained from the calibration curve prepared with vitamin C at 62.5-1000 µ M concentrations and multiplying the corresponding concentration by two because of 1:2 stoichiometry of vitamin C with FeSO 4 .
In general, FRAP results were similar to those of DPPH• radical scavenging activities. As the length of the alkyl chain was increased from 5 to 15 carbon atoms, the FRAP activities in most compounds decreased, evident from the decreasing trend of FRAP values from compounds 7a, 8a, and 9a to 7k, 8k, and 9k. The lowest antioxidant activities were determined with 8k and 9k, with the longest alkyl chain. The same irregularity was observed with FRAP tests as with DPPH• scavenging tests in compounds 9b and 9h-j, showing unexpected activity. Nevertheless, the highest activities were obtained from compound 9b in DPPH• and FRAP tests. Figure 4 ). When antioxidant activities of these three series are examined, it can be seen that 9a-k is the most active, 8a-k is the second, and 7a-k is the least active. 
Methods
The known compounds 1, 2, and 3 were synthesized according to the literature. 01 mol for each) in DMF (10 mL each) was added KOH (1.12 g, 0.02 mol each) and the resulting mixture was stirred at room temperature for 1 h. Then alkyl bromide (0.03 mol each) was added dropwise, and the reaction mixture was stirred overnight at room temperature. Then the reaction mixture was poured into 20 mL of water. The resulting mixture was extracted with CH 2 Cl 2 (2 × 20 mL). The combined organic layer was washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in a vacuum to give crude products 7a-k, 8a-k, and 9a-k, which were purified by column chromatography using a mixture of n-hexane-chloroform (8.5:0.5) as eluent (yields are in Tables 1, 4 , and 7). The structures of compounds 7a-k, 8a-k, and 9a-k were assigned on the basis of NMR, IR, and mass spectral analyses (Tables 1-9) , respectively, and they were named 2- ( Tables 8-10 .
In vitro antibacterial activity
The newly synthesized compounds were screened for their in vitro antibacterial activity against Escherichia coli ATCC35218, Yersinia pseudotuberculosis ATCC911, Pseudomonas aeruginosa ATCC43288, Enterococcus faecalis ATCC29212, Staphylococcus aureus ATCC25923, Bacillus cereus 709 Roma, Mycobacterium smegmatis ATCC607, Candida albicans ATCC60193, and Saccharomyces cerevisiae RSKK 251, which were obtained from Refik Saydam Hygiene Center (Ankara, Turkey). All tested compounds were dissolved in hexane and diluted with dimethyl sulfoxide (DMSO) to prepare solutions of 10.0 mg/mL.
The antimicrobial effects of the compounds were tested quantitatively in respective broth medium by using double dilution, and the minimal inhibition concentration (MIC) values (µ g/mL) were determined.
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The antibacterial and antifungal assays were performed in Mueller-Hinton broth (MH) (Difco, Detroit, MI, USA) at pH 7.3 and buffered Yeast Nitrogen Base (Difco) at pH 7.0, respectively. Brain Heart Infusion broth (BHI) (Difco) was used for M. smegmatis. 54 The MIC was defined as the lowest concentration that showed no growth. Ampicillin (10.0 mg/mL), streptomycin (10.0 mg/mL), and fluconazole (5.0 mg/mL) were used as standard antibacterial and antifungal drugs, respectively. Hexane with a dilution of 1:10 with DMSO was used as solvent. The smallest concentration with which the growth of the test microorganism was totally inhibited is reported as MIC ( µ g/mL) value (Table 10 ).
In vitro antioxidant activity tests
DPPH• scavenging test
DPPH• radical scavenging activity of the compounds was determined by UV spectra at 517 nm ( Figure 2 ).
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The assay is based on the absorbance change of the DPPH• when deactivated by the antioxidants, which is observed with the naked eye as a color change from purple to yellow. Briefly, 750 µ L of the compound solutions was mixed with 750 µ L of a 100 µ M DPPH• in methanol and vortexed. The compound solutions were tested at five different concentrations prepared with a twofold serial dilution starting with the highest concentration estimated with a pretest measurement. DPPH• radical scavenging activity was evaluated by using ascorbic acid as antioxidant standard, and the values are expressed as SC 50 (mg/mL), the concentration of the sample resulting in 50% scavenging of the radicals. Low SC 50 values represent high antioxidant activity. In order to make a correlation with the results of the FRAP test, the results of the DPPH• scavenging test were also expressed in terms of %scavenging, the percentage of the DPPH• radicals remaining after reacting DPPH• with the sample at 0.5 mg/mL concentration in comparison to the initial value.
Ferric reducing/antioxidant power (FRAP) test
The antioxidant activities of the compounds were determined by FRAP assay. 36 The method is based on the measurement of the iron reducing capacities of the compounds. Working FRAP reagent was prepared by mixing 150 mL of 0.3 M acetate buffer at pH 3.6 with 15 mL of 10 mM TPTZ solution in 40 mM HCl and 15 mL of 20 mM FeCl 3 .6H 2 O. The preparation of FRAP reagent was modified using a methanol-water mixture in 3:2 ratio to make the medium more compatible with the compounds of relatively nonpolar nature; 50 µL of the sample was mixed with 1.5 mL of freshly prepared FRAP reagent. The absorbance was read after an incubation period of 20 min at room temperature at 595 nm against distilled water (Figure 3) . A calibration curve was constructed using aqueous solutions of vitamin C in the concentration range of 62.5-1000 µ M. The absorbance of the reagent blank and sample blank was subtracted from that of the samples. The corresponding vitamin C concentrations for the compound test results were determined from the calibration curve, and the results are expressed as µ M FRAP by multiplying the value obtained from the calibration graph by two, as two to one stoichiometry is present between vitamin C and FeSO 4 . High FRAP values mean high total antioxidant activity ( Figure 3 ).
Conclusion
A new synthetic method was used to synthesize 4-alkoxy-2-arylquinoline derivatives (7a-k, 8a-k, and 9a-k) starting from flavonone [2-aryl-2,3-dihydroquinolin-4(1H )-ones]. All the newly synthesized compounds were tested for their antibacterial, antifungal, and antituberculosis properties against a panel of standardized microorganisms, using ampicillin, streptomycin, and fluconazole for comparison. The observed MIC values of the compounds (7a-k, 8a-k, and 9a-k) against M. smegmatis were in the range of 62.5-500 µ g/mL.
m −Fluoride substituted new compounds 8a-k gave high antituberculosis activity (MIC, 62.5-125 µ g/mL). The compounds showed relatively good antioxidant activities in DPPH• radical scavenging and FRAP tests. This study indicated that the results of the DPPH and FRAP assays provide essentially identical information in regard to the antioxidant capability of the compounds, and so it is difficult to establish what additional information could be gained apart from alkyl chain length. When the alkyl chain length increased from five carbons (7a, 8a, and 9a) to 15 carbons (7k, 8k, and 9k), the antioxidant capacity decreased in both methods. The antimicrobial data observed against M. smegmatis suggest that the new chemotype is promising in the search for an antituberculosis drug candidate lead. Synthetic or natural flavonones should be evaluated for their potential use in the synthesis of new bioactive quinoline derivatives.
